Brief: Prostatype Genomics Q6 EBITDA Loss Widens To SEK 4.7 Million
Feb 19 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q6 NET SALES SEK 0.3 MILLION VERSUS SEK 10,000 YEAR AGO
* Q6 EBITDA LOSS SEK 4.7 MILLION VERSUS LOSS SEK 1.8 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr4z20j9
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue